Seascape Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,927
Closed -$242K 91
2021
Q3
$242K Hold
1,927
0.12% 87
2021
Q2
$239K Buy
+1,927
New +$242K 0.12% 88

Other funds holding MDT

Seascape Capital Management's MDT Position: Q4 2021 in Review

Seascape Capital Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,927 shares — an estimated $242K sold.

Seascape Capital Management first reported a position in MDT in Q2 2021 and held it in 2 quarters. The position peaked at $242K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Seascape Capital Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Seascape Capital Management sold 1,927 Medtronic shares in Q4 2021, an estimated $242K.
  • Seascape Capital Management first reported a position in Medtronic in Q2 2021 and held it in 2 quarters.
  • Seascape Capital Management's Medtronic position peaked at $242K in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Seascape Capital Management's 13F filing for Q4 2021, filed 27 Jan 2022.